CXCL12 and breast cancer: This process results in the release of soluble factors from the bone matrix including insulin-like growth factor 1 (IGF1) and CXCL12, which stimulate activation of the PI3K-AKT pathway thereby enhancing BC cell proliferation and survival in the bone [117,118].